This lowered activity in AD mice is in agreement with Wu et al. (2018) who used the 3xTg-AD mouse, containing mutations in amyloid, tau, and the PS1 gene, and found that AD mice had lower total daily activity in running compared to WT mice. This evidence concerns the gene MAPT and Alzheimer disease.